US Stock MarketDetailed Quotes

ACXP Acurx Pharmaceuticals

Watchlist
  • 1.830
  • -0.030-1.61%
Trading Nov 4 15:55 ET
29.73MMarket Cap-1577P/E (TTM)

Acurx Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-30.45%6.36M
24.27%8.92M
-17.97%7.47M
-17.97%7.47M
-33.51%7.05M
0.59%9.15M
-35.23%7.18M
-29.69%9.11M
-29.69%9.11M
-26.64%10.61M
-Cash and cash equivalents
-30.45%6.36M
24.27%8.92M
-17.97%7.47M
-17.97%7.47M
-33.51%7.05M
0.59%9.15M
-35.23%7.18M
-29.69%9.11M
-29.69%9.11M
-26.64%10.61M
Receivables
--51.13K
--0
--129.16K
--129.16K
----
----
----
--0
--0
----
-Other receivables
--51.13K
----
--129.16K
--129.16K
----
----
----
----
----
----
Prepaid assets
87.24%168.41K
-9.05%187.91K
-60.08%105.78K
-60.08%105.78K
-68.70%105.72K
-23.03%89.94K
-13.72%206.6K
-10.28%264.96K
-10.28%264.96K
-36.33%337.81K
Total current assets
-28.75%6.58M
23.34%9.11M
-17.78%7.71M
-17.78%7.71M
-34.60%7.16M
0.29%9.24M
-34.77%7.39M
-29.25%9.38M
-29.25%9.38M
-26.98%10.95M
Non current assets
Total non current assets
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total assets
-28.75%6.58M
23.34%9.11M
-17.78%7.71M
-17.78%7.71M
-34.60%7.16M
-0.25%9.24M
-34.77%7.39M
-29.25%9.38M
-29.25%9.38M
-26.98%10.95M
Liabilities
Current liabilities
Payables
-21.31%10.13K
-50.02%9.2K
-87.11%3.81K
-87.11%3.81K
97.34%11.72K
123.44%12.88K
189.69%18.41K
-53.39%29.54K
-53.39%29.54K
-51.08%5.94K
-Other payable
-21.31%10.13K
-50.02%9.2K
-87.11%3.81K
-87.11%3.81K
97.34%11.72K
123.44%12.88K
189.69%18.41K
-53.39%29.54K
-53.39%29.54K
-51.08%5.94K
Current accrued expenses
4.37%3.1M
51.32%3.08M
55.94%2.32M
55.94%2.32M
241.66%3M
572.05%2.97M
233.06%2.04M
447.13%1.49M
447.13%1.49M
96.24%879.49K
Current liabilities
4.42%3.15M
49.96%3.11M
47.57%3.04M
47.57%3.04M
172.69%3.22M
537.17%3.02M
227.63%2.07M
144.30%2.06M
144.30%2.06M
65.92%1.18M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
4.42%3.15M
49.96%3.11M
47.57%3.04M
47.57%3.04M
172.69%3.22M
537.17%3.02M
227.63%2.07M
144.30%2.06M
144.30%2.06M
65.92%1.18M
Shareholders'equity
Share capital
23.00%16K
35.00%15.76K
24.42%14.47K
24.42%14.47K
12.18%13.01K
26.72%13.01K
13.73%11.67K
13.82%11.63K
13.82%11.63K
14.48%11.59K
-common stock
23.00%16K
35.00%15.76K
24.42%14.47K
24.42%14.47K
12.18%13.01K
26.72%13.01K
13.73%11.67K
13.82%11.63K
13.82%11.63K
14.48%11.59K
Retained earnings
-37.19%-61.72M
-38.64%-57.6M
-37.73%-53.22M
-37.73%-53.22M
---48.1M
---44.99M
---41.54M
---38.64M
---38.64M
----
Paid-in capital
27.23%65.13M
35.73%63.58M
25.96%57.87M
25.96%57.87M
15.27%52.03M
26.05%51.19M
17.41%46.84M
17.96%45.94M
17.96%45.94M
18.18%45.13M
Gains losses not affecting retained earnings
----
----
----
----
----
----
----
----
----
-47.90%-35.38M
Total stockholders'equity
-44.86%3.43M
12.94%6M
-36.20%4.67M
-36.20%4.67M
-59.70%3.93M
-29.24%6.22M
-50.31%5.31M
-41.06%7.32M
-41.06%7.32M
-31.62%9.76M
Total equity
-44.86%3.43M
12.94%6M
-36.20%4.67M
-36.20%4.67M
-59.70%3.93M
-29.24%6.22M
-50.31%5.31M
-41.06%7.32M
-41.06%7.32M
-31.62%9.76M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -30.45%6.36M24.27%8.92M-17.97%7.47M-17.97%7.47M-33.51%7.05M0.59%9.15M-35.23%7.18M-29.69%9.11M-29.69%9.11M-26.64%10.61M
-Cash and cash equivalents -30.45%6.36M24.27%8.92M-17.97%7.47M-17.97%7.47M-33.51%7.05M0.59%9.15M-35.23%7.18M-29.69%9.11M-29.69%9.11M-26.64%10.61M
Receivables --51.13K--0--129.16K--129.16K--------------0--0----
-Other receivables --51.13K------129.16K--129.16K------------------------
Prepaid assets 87.24%168.41K-9.05%187.91K-60.08%105.78K-60.08%105.78K-68.70%105.72K-23.03%89.94K-13.72%206.6K-10.28%264.96K-10.28%264.96K-36.33%337.81K
Total current assets -28.75%6.58M23.34%9.11M-17.78%7.71M-17.78%7.71M-34.60%7.16M0.29%9.24M-34.77%7.39M-29.25%9.38M-29.25%9.38M-26.98%10.95M
Non current assets
Total non current assets --0--0--0--0--0--0--0--0--0--0
Total assets -28.75%6.58M23.34%9.11M-17.78%7.71M-17.78%7.71M-34.60%7.16M-0.25%9.24M-34.77%7.39M-29.25%9.38M-29.25%9.38M-26.98%10.95M
Liabilities
Current liabilities
Payables -21.31%10.13K-50.02%9.2K-87.11%3.81K-87.11%3.81K97.34%11.72K123.44%12.88K189.69%18.41K-53.39%29.54K-53.39%29.54K-51.08%5.94K
-Other payable -21.31%10.13K-50.02%9.2K-87.11%3.81K-87.11%3.81K97.34%11.72K123.44%12.88K189.69%18.41K-53.39%29.54K-53.39%29.54K-51.08%5.94K
Current accrued expenses 4.37%3.1M51.32%3.08M55.94%2.32M55.94%2.32M241.66%3M572.05%2.97M233.06%2.04M447.13%1.49M447.13%1.49M96.24%879.49K
Current liabilities 4.42%3.15M49.96%3.11M47.57%3.04M47.57%3.04M172.69%3.22M537.17%3.02M227.63%2.07M144.30%2.06M144.30%2.06M65.92%1.18M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities 4.42%3.15M49.96%3.11M47.57%3.04M47.57%3.04M172.69%3.22M537.17%3.02M227.63%2.07M144.30%2.06M144.30%2.06M65.92%1.18M
Shareholders'equity
Share capital 23.00%16K35.00%15.76K24.42%14.47K24.42%14.47K12.18%13.01K26.72%13.01K13.73%11.67K13.82%11.63K13.82%11.63K14.48%11.59K
-common stock 23.00%16K35.00%15.76K24.42%14.47K24.42%14.47K12.18%13.01K26.72%13.01K13.73%11.67K13.82%11.63K13.82%11.63K14.48%11.59K
Retained earnings -37.19%-61.72M-38.64%-57.6M-37.73%-53.22M-37.73%-53.22M---48.1M---44.99M---41.54M---38.64M---38.64M----
Paid-in capital 27.23%65.13M35.73%63.58M25.96%57.87M25.96%57.87M15.27%52.03M26.05%51.19M17.41%46.84M17.96%45.94M17.96%45.94M18.18%45.13M
Gains losses not affecting retained earnings -------------------------------------47.90%-35.38M
Total stockholders'equity -44.86%3.43M12.94%6M-36.20%4.67M-36.20%4.67M-59.70%3.93M-29.24%6.22M-50.31%5.31M-41.06%7.32M-41.06%7.32M-31.62%9.76M
Total equity -44.86%3.43M12.94%6M-36.20%4.67M-36.20%4.67M-59.70%3.93M-29.24%6.22M-50.31%5.31M-41.06%7.32M-41.06%7.32M-31.62%9.76M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data